• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后双侧急性虹膜色素脱失(BADI)

Bilateral Acute Depigmentation of the Iris (BADI) following Covid-19 Infection.

机构信息

Ophthalmology Department, Hospital Universitario San Juan de Alicante, Sant Joan d'Alacant, Spain.

出版信息

Ocul Immunol Inflamm. 2023 Aug;31(6):1230-1231. doi: 10.1080/09273948.2022.2113801. Epub 2022 Aug 30.

DOI:10.1080/09273948.2022.2113801
PMID:36040969
Abstract

PURPOSE

To present a case of bilateral acute iris depigmentation after covid 19 infection.

CASE REPORT

A 55-year-old female presented with binocular pain and blurred vision a month after being diagnosed with severe acute respiratory syndrome - coronavirus-2 (SARS-CoV-2). She presented pigment dispersion in the anterior chamber and pigment depositions on the corneal endothelium. The patient was treated with dexamethasone and during follow-up visits, the pigment dispersion decreased and the symptoms ceased.

CONCLUSIONS

Covid-19 infection may be associated with rare ocular disorders such as BADI.

摘要

目的

报告一例新冠病毒感染后双侧急性虹膜退色素病变。

病例报告

一名 55 岁女性,在诊断为严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染一个月后出现双眼疼痛和视力模糊。她表现为前房色素播散和角膜内皮色素沉着。患者接受了地塞米松治疗,在随访过程中,色素播散减少,症状消失。

结论

新冠病毒感染可能与罕见的眼部疾病如 BADI 有关。

相似文献

1
Bilateral Acute Depigmentation of the Iris (BADI) following Covid-19 Infection.新冠病毒感染后双侧急性虹膜色素脱失(BADI)
Ocul Immunol Inflamm. 2023 Aug;31(6):1230-1231. doi: 10.1080/09273948.2022.2113801. Epub 2022 Aug 30.
2
Bilateral Acute Depigmentation of Iris (BADI) Post COVID Infection following Systemic Moxifloxacin Therapy.新冠感染全身应用莫西沙星治疗后出现双侧急性虹膜色素脱失(BADI)
Ocul Immunol Inflamm. 2023 Aug;31(6):1210-1212. doi: 10.1080/09273948.2022.2069126. Epub 2022 Apr 29.
3
Bilateral acute depigmentation of the iris (BADI): first reported case in Brazil.双侧虹膜急性色素脱失(BADI):巴西首例报告病例。
Arq Bras Oftalmol. 2013 Jan-Feb;76(1):42-4. doi: 10.1590/s0004-27492013000100012.
4
A case of bilateral acute depigmentation of the Iris in one of two identical twins.一例双胞胎中一例双侧急性虹膜色素脱失。
BMC Ophthalmol. 2020 Jan 6;20(1):13. doi: 10.1186/s12886-019-1282-z.
5
COVID-19 Associated Bilateral Acute Iris Transillumination.新型冠状病毒肺炎相关双侧急性虹膜透照缺损
Ocul Immunol Inflamm. 2021 May 19;29(4):719-721. doi: 10.1080/09273948.2021.1933073. Epub 2021 Jun 14.
6
[Bilateral acute depigmentation of the iris syndrome].[虹膜综合征双侧急性色素脱失]
J Fr Ophtalmol. 2011 May;34(5):309-12. doi: 10.1016/j.jfo.2010.12.007. Epub 2011 May 4.
7
COVID-19-related bilateral acute de-pigmentation of iris with ocular hypertension.COVID-19 相关的双侧急性虹膜色素脱失伴眼压升高。
Indian J Ophthalmol. 2022 Aug;70(8):3136-3139. doi: 10.4103/ijo.IJO_75_22.
8
Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.双侧急性虹膜脱色素(BADI)和双侧急性虹膜透光性(BAIT):来自巴西某中心的病例系列。
Arq Bras Oftalmol. 2024 Apr 19;87(4):e2023. doi: 10.5935/0004-2749.2023-0219. eCollection 2024.
9
Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update.双侧急性虹膜退色症(BADI)和双侧急性虹膜光透过性(BAIT)-更新。
Turk J Ophthalmol. 2022 Oct 28;52(5):342-347. doi: 10.4274/tjo.galenos.2022.09552.
10
Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection.急性 COVID-19 感染后双侧急性虹膜退色(BADI)和双侧急性虹膜透光(BAIT)。
Ocul Immunol Inflamm. 2023 Aug;31(6):1163-1168. doi: 10.1080/09273948.2022.2103832. Epub 2022 Sep 9.

引用本文的文献

1
Bilateral Acute Iris Transillumination Following Systemic Moxifloxacin Intake in the Greek Population.希腊人群中全身使用莫西沙星后出现双侧急性虹膜透照现象
Ophthalmol Ther. 2025 May;14(5):1157-1168. doi: 10.1007/s40123-025-01135-w. Epub 2025 Apr 2.
2
Conditional reprogrammed human limbal epithelial cell model for anti-SARS-CoV-2 drug screening.用于抗SARS-CoV-2药物筛选的条件重编程人角膜缘上皮细胞模型
Heliyon. 2024 Apr 23;10(9):e30044. doi: 10.1016/j.heliyon.2024.e30044. eCollection 2024 May 15.